BNIP3 as an atypical representative of the Bcl-2 protein family. Part 2: Regulation of the expression and activity of BNIP3 protein and its role in tumorigenesis
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue
Abstract
BNIP3 belongs to the Bcl-2 protein family that regulates programmed cell death. It is the only known pro-apoptotic protein expressed during hypoxia and this effect is determined by the HIF-1 responsive element in the bnip3 promoter. However, there is evidence that hypoxia is not a sufficient factor to activate BNIP3; possible cell death dependent on this protein occurs as a result of secondary effects of oxygen deprivation, such as acidosis. BNIP3 expression is also regulated by other factors, such as E2F-1, NF-κB, and Rb during hypoxia and nitrogen oxide during normoxia. Posttranslational modifications also seem to be essential for BNIP3 activity, but their actual significance is still unclear. Phosphorylation of BNIP3 by PKC promotes its accumulation under hypoxic conditions, but phosphorylation by CK2 can accelerate its degradation. In turn, glycosylation and interactions with anti-apoptotic Bcl-2 proteins suppress BNIP3 activity. Our knowledge about the role of BNIP3 protein in tumor progression is incomplete. It seems to be dependent on the stage of tumor progression. Tumor cells evolved multiple mechanisms of silencing BNIP3 expression or activity and promoter methylation is one of the most frequently observed among them
Authors and Affiliations
Ewelina Swoboda, Leon Strządała
Keywords
Related Articles
- EP ID EP66372
- DOI -
- Views 161
- Downloads 0
Najnowsze zalecenia dotyczące zastosowania nowych doustnych antykoagulantów w rutynowej praktyce
Wprowadzenie doustnych antykoagulantów niebędących antagonistami witaminy K (non-vitamin K antagonist oral anticoagulants, NOAC) stało się przełomem w leczeniu przeciwkrzepliwym i przewiduje się, że liczba osób przyjmują...
A remedy against obesity? The role of lactoferrin in the metabolism of glucose and lipids
Obesity, dyslipidemia, hyperglycemia/type II diabetes and hypertension together constitute the so-called metabolic syndrome. Frequency of occurrence of these serious metabolic disturbances is associated with life style a...
Heterogenność ludzkiego genu WT1
Gen WT1, charakteryzujący się niezwykle złożoną strukturą, jest umiejscowiony w obrębie chromosomu 11. Bierze udział w regulacji wzrostu i rozwoju komórek, ma także znaczny wpływ na etapy funkcjonowania organizmu. Gen WT...
Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
Various and different peptides products resulting from enzymatic protein cleavage of Amyloid Precursor Proteins (APP) are the main agents in the pathophysiology of Alzheimer’s disease (AD). Although relatively well-known...
Białka w oporności wielolekowej nowotworów
Wielolekooporność definiowana jest jako brak wrażliwości na podawane leki, które nie wykazują strukturalnego podobieństwa, a ponadto mają zróżnicowane molekularne punkty uchwytu. Nowotwory dysponują licznymi mechanizmami...